REQUEST A DEMO
Total
USD $0.00
Search more companies

Insu-Farma S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmacies and Drug Stores
Full name: Insu-Farma S.A.S. Profile Updated: May 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Insu-Farma S.A.S. is an enterprise based in Colombia. Its main office is in Envigado. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on February 25, 2022. The total number of employees is currently 2 (2026). The latest financial highlights indicate a net sales revenue increase of 1013.25% in 2025. Over the same period, its total assets grew by 68.02%.

Headquarters
Cr 48 # 25Aa Sur 70 Of 309 Complex Las Vegas
Envigado; Antioquia;

Contact Details: Purchase the Insu-Farma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Insu-Farma S.A.S. report to view the information.
Financial Auditors:
Purchase the Insu-Farma S.A.S. report to view the information.
Incorporation Date:
February 25, 2022
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Insu-Farma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
1013.25%
Total Operating Revenue
1013.25%
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
68.02%
Total Equity
40.95%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?